SHANGHAI – As part of health care reforms, China has been piloting "zero markups" for drugs sold at hospitals for several years in a bid to reduce and rationalize the cost of health care. According to the State Council work plan, this year will see a significant expansion of the pilot, with half of all county-level hospitals and one city per province expected to have adopted the new drug pricing policy by the end of the year.